3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
43
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
5
Gastrointestinal
2
Thoracic
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Leukemia, Myeloid, Acute
30
Hematologic Neoplasms
20
Leukemia
13
Multiple Myeloma
9
Myelodysplastic Syndromes
8
Lymphoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Neoplasms
7
Recurrence
6
Lymphoma, Non-Hodgkin
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, B-Cell
3
Leukemia, Myelomonocytic, Chronic
3
Hodgkin Disease
3
Vitamin D Deficiency
2
Neoplasms, Plasma Cell
2
Neoplasm, Residual
2
Motor Activity
2
Invasive Fungal Infections
2
Immunoglobulin Light-chain Amyloidosis
2
Hematologic Diseases
2
Cardiovascular Diseases
2
Wilms Tumor
1
Stomatitis
1
Sprains and Strains
1
Shoulder Injuries
1
Shoulder Dislocation
1
Sepsis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Fatigue
×
Other hematologic neoplasm
×
Clear all
NCT03403075
2025-06-11
ETAF
Azienda USL Reggio Emilia - IRCCS
Phase NA
Completed
46 enrolled